Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Medical Isotope Market, by Type
1.4.2 North America Medical Isotope Market, by End User
1.4.3 North America Medical Isotope Market, by Application
1.4.4 North America Medical Isotope Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent Strategies Deployed in Medical Isotopes Market
Chapter 5. North America Medical Isotope Market by Type
5.1 North America Radioisotopes Market by Region
5.2 North America Stable Isotopes Market by Region
Chapter 6. North America Medical Isotope Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Diagnostic Centers Market by Country
6.3 North America Research Institutes Market by Country
Chapter 7. North America Medical Isotope Market by Application
7.1 North America Diagonostic Market by Country
7.2 North America Nuclear Therapy Market by Country
Chapter 8. North America Medical Isotope Market by Country
8.1 US Medical Isotope Market
8.1.1 US Medical Isotope Market by Type
8.1.2 US Medical Isotope Market by End User
8.1.3 US Medical Isotope Market by Application
8.2 Canada Medical Isotope Market
8.2.1 Canada Medical Isotope Market by Type
8.2.2 Canada Medical Isotope Market by End User
8.2.3 Canada Medical Isotope Market by Application
8.3 Mexico Medical Isotope Market
8.3.1 Mexico Medical Isotope Market by Type
8.3.2 Mexico Medical Isotope Market by End User
8.3.3 Mexico Medical Isotope Market by Application
8.4 Rest of North America Medical Isotope Market
8.4.1 Rest of North America Medical Isotope Market by Type
8.4.2 Rest of North America Medical Isotope Market by End User
8.4.3 Rest of North America Medical Isotope Market by Application
Chapter 9. Company Profiles
9.1 Canadian Nuclear Laboratories (Atomic Energy of Canada Limited)
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.3 SWOT Analysis
9.2 ITM Isotope Technologies Munich SE
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Partnerships, Collaborations, and Agreements:
9.2.3 SWOT Analysis
9.3 ECZACIBAŞI-MONROL
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Partnerships, Collaborations, and Agreements:
9.3.3 SWOT Analysis
9.4 NorthStar Medical Radioisotopes, LLC
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Partnerships, Collaborations, and Agreements:
9.4.3 SWOT Analysis
9.5 Iba SA
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 Mallinckrodt PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 GE HealthCare Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Nordion Inc. (Sotera Health LLC)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.9 Bayer AG
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.6 SWOT Analysis
9.10. Siemens Healthineers AG (Siemens AG)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis
Unique Offerings 